UBS Cuts Price Target on CSX Corp. (CSX) as Weak Markets Drive Ongoing Pressure

After-Hours Stock Movers 01/12: (ARNA) (MET) (YUM) Higher; (F) (CSX) (EQY) Lower (more...)

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) 7.6% HIGHER; Boehringer Ingelheim and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that they have signed an exclusive agreement to conduct joint research to identify drug candidates targeting an undisclosed G protein-coupled receptor (GPCR), which belongs to the group of orphan CNS receptors. An "orphan receptor" is structurally related to a family of proteins that are known to act as functional cell-surface receptors but whose ligand has not yet been identified.

Ruby Tuesday (NYSE:... More

Market Wrap: Crude Touches 13-Year Lows; MetLife Looks to Sell Key Assets; Ford Plans Substantial Profit-Based Dividend

Market wrap for January 12th

End of the Day: S&P 500 up 15.0 to 1,938.68; Dow Jones up 117.7 to 16,516.22; Nasdaq up 47.9 to 4,685.9

Market Brief: Markets seemingly fought off a large sell-off in the oil & exploration segment as crude prices continued to be weak. Crude prices moved below $30 per barrel for the first time since 2003 with lingering concerns of lagging demand from China and continued high output playing on investors' fears. For more color,... More

CSX Corp. (CSX) Tops Q4 EPS by 1c

CSX Corp. (NASDAQ: CSX) reported Q4 EPS of $0.48, $0.01 better than the analyst estimate of $0.47.

Fourth quarter revenue declined 13 percent as pricing gains were more than offset by the impact of lower fuel recovery, a 6 percent volume decline and continued transition in the companys... More

Trading Radar for 1/12: Anthem (ANTM), CSX Corp. (CSX), Progress Software (PRGS) Report

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

Anthem (NYSE: ANTM) - consensus EPS $1.24
IHS (NYSE: IHS) - consensus EPS... More